| 1 |
31928160 | Syringaresinol as a novel androgen receptor antagonist against wild and mutant androgen receptors for the treatment of castration-resistant prostate cancer: molecular docking, in-vitro and molecular dynamics study. | 2021 Feb |
1 |
| 2 |
30680195 | Androgen receptor and soy isoflavones in prostate cancer. | 2019 Feb |
2 |
| 3 |
27088761 | Equol inhibits prostate cancer growth through degradation of androgen receptor by S-phase kinase-associated protein 2. | 2016 Jul |
1 |
| 4 |
23872207 | Phytoestrogens selective for the estrogen receptor beta exert anti-androgenic effects in castration resistant prostate cancer. | 2014 Jan |
1 |
| 5 |
22422102 | Prostate Cancer Chemoprevention Targeting High Risk Populations: Model for Trial Design and Outcome Measures. | 2012 |
3 |
| 6 |
22200028 | Induction of cancer cell death by isoflavone: the role of multiple signaling pathways. | 2011 Oct |
2 |
| 7 |
18687691 | Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells. | 2008 Oct 10 |
7 |
| 8 |
18852123 | Genistein down-regulates androgen receptor by modulating HDAC6-Hsp90 chaperone function. | 2008 Oct |
1 |
| 9 |
17585029 | Isoflavone-rich soy protein isolate suppresses androgen receptor expression without altering estrogen receptor-beta expression or serum hormonal profiles in men at high risk of prostate cancer. | 2007 Jul |
1 |